Insmed Inc (INSM.OQ)
26 Apr 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|61||2012||Non-Executive Chairman of the Board|
|48||2012||President, Chief Executive Officer, Director|
|54||2017||Chief Financial Officer|
|48||2013||Senior Vice President- Human Resource and Corporate Services|
|2010||Chief Technology Officer|
- BRIEF-Insmed Inc Submits NDA To FDA For ALIS
- BRIEF-Insmed Reports Q4 Loss Per Share $0.85
- BRIEF-Insmed Prices Public Offering Of $400 Mln Principal Amount Of Its Convertible Senior Notes
- BRIEF-Insmed Announces Proposed Public Offering Of Convertible Senior Notes
- BRIEF-Insmed Announces Additional Data From ALIS Phase 3 Clinical Program